Release Date: 29/04/16 09:29 Summary: Quarterly Activities Report-BRB.AX Price Sensitive: Yes Download Document 4.31MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%